These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8882902)

  • 61. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Progress in the medicinal chemistry of dopaminergic agents.
    Schaus JM; Kornfeld EC; Titus RD; Nichols CL; Huser DL; Clemens JA; Smalstig EB; Fuller RW
    Drug Des Discov; 1993; 9(3-4):323-32. PubMed ID: 8104521
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Catalytic mechanism of cyclophilin as observed in molecular dynamics simulations: pathway prediction and reconciliation of X-ray crystallographic and NMR solution data.
    Trzesniak D; van Gunsteren WF
    Protein Sci; 2006 Nov; 15(11):2544-51. PubMed ID: 17075133
    [TBL] [Abstract][Full Text] [Related]  

  • 64. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
    Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cis-cis and trans-perp HOONO: action spectroscopy and isomerization kinetics.
    Fry JL; Nizkorodov SA; Okumura M; Roehl CM; Francisco JS; Wennberg PO
    J Chem Phys; 2004 Jul; 121(3):1432-48. PubMed ID: 15260688
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 67. p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects.
    Cannon JG; Amoo VE; Long JP; Bhatnagar RK; Flynn JR
    J Med Chem; 1986 Dec; 29(12):2529-34. PubMed ID: 3783613
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Steric aspects of dopaminergic drugs.
    Miller DD
    Fed Proc; 1978 Aug; 37(10):2392-5. PubMed ID: 28250
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and biochemical evaluation of N-(1-substituted-cycloalkyl)-beta-(3,4-dimethoxy; or dihydroxy) phenethylamines: potential dopaminergic agents.
    Shafik RM; Rida SM; Eshba NH; Abdel-Kreem MF; el-Dardiry SA
    Farmaco; 1995 Apr; 50(4):273-9. PubMed ID: 7669172
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline.
    Cannon JG; Lee T; Goldman HD; Long JP; Flynn JR; Verimer T; Costall B; Naylor RJ
    J Med Chem; 1980 Jan; 23(1):1-5. PubMed ID: 7188974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stereoselective synthesis of functionalised carbocyclic amides: construction of the syn-(4aS,10bS)-phenanthridone skeleton.
    Ahmad S; Swift MD; Farrugia LJ; Senn HM; Sutherland A
    Org Biomol Chem; 2012 May; 10(19):3937-45. PubMed ID: 22476208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A stereochemical and conformational model of dopaminergic agonist and antagonist activity: further evaluation.
    Froimowitz M; Baldessarini RJ
    J Pharm Sci; 1987 Jul; 76(7):557-64. PubMed ID: 3668819
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure-activity relationships in the trans-hexahydroindolo[4,3-ab]phenanthridine ("benzergoline") series. 2. Resolution, absolute configuration, and dopaminergic activity of the selective D1 agonist CY 208-243 and its implication for an "extended rotamer-based dopamine receptor model".
    Seiler MP; Floersheim P; Markstein R; Widmer A
    J Med Chem; 1993 Apr; 36(8):977-84. PubMed ID: 8097540
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biologically active conformers of phenothiazines and thioxanthenes. Further evidence for a ligand model of dopamine D2 receptor antagonists.
    Froimowitz M; Cody V
    J Med Chem; 1993 Jul; 36(15):2219-27. PubMed ID: 8101879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation and structural analysis of (±)-cis-ethyl 2-sulfanylidenedecahydro-1,6-naphthyridine-6-carboxylate and (±)-trans-ethyl 2-oxooctahydro-1H-pyrrolo[3,2-c]pyridine-5-carboxylate.
    Schwehm C; Lewis W; Blake AJ; Kellam B; Stocks MJ
    Acta Crystallogr C Struct Chem; 2014 Dec; 70(Pt 12):1161-8. PubMed ID: 25471418
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and pharmacological effects of the enantiomers of the N-phenethyl analogues of the ortho and para e- and f-oxide-bridged phenylmorphans.
    Zezula J; Singer L; Przybył AK; Hashimoto A; Dersch CM; Rothman RB; Deschamps J; Lee YS; Jacobson AE; Rice KC
    Org Biomol Chem; 2008 Aug; 6(16):2868-83. PubMed ID: 18688479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dimeric nanocapsule induces conformational change.
    Maerz AK; Thomas HM; Power NP; Deakyne CA; Atwood JL
    Chem Commun (Camb); 2010 Feb; 46(8):1235-7. PubMed ID: 20449261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects.
    Cannon JG; Suarez-Gutierrez C; Lee T; Long JP; Costall B; Fortune DH; Naylor RJ
    J Med Chem; 1979 Apr; 22(4):341-7. PubMed ID: 571020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT.
    Froimowitz M; Patrick KS; Cody V
    Pharm Res; 1995 Oct; 12(10):1430-4. PubMed ID: 8584475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preferred conformers for the pharmacologically typical and atypical antipodes of phenylmorphan opiates.
    Froimowitz M
    J Med Chem; 1984 Sep; 27(9):1234-7. PubMed ID: 6471078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.